Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
49,625,327
-
Total 13F shares
-
6,080,809
-
Share change
-
-265,373
-
Total reported value
-
$19,096,287
-
Price per share
-
$3.14
-
Number of holders
-
22
-
Value change
-
-$834,393
-
Number of buys
-
8
-
Number of sells
-
5
Institutional Holders of Candel Therapeutics, Inc. - Common stock, par value $0.0001 per share (CADL) as of Q3 2022
As of 30 Sep 2022 Candel Therapeutics, Inc. - Common stock, par value $0.0001 per share (CADL) had 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,080,809 shares of stock of the company.
Largest 10 holders included Northpond Ventures, LLC, FRANKLIN RESOURCES INC, FMR LLC, Sands Capital Ventures, LLC, VANGUARD GROUP INC, Point72 Asset Management, L.P., BRIDGEWAY CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., and STATE STREET CORP.
This table shows 22 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.